Business
Result of Meeting
Ovoca Bio plc, soon to be renamed Talisman Metals PLC, announced that all resolutions were passed at its General Meeting and AGM, allowing for the completion of the acquisition of Tadeen International Limited and the subsequent issuance of New Ordinary Shares, Consideration Shares, and Fundraising Shares. The company expects the Enlarged Share Capital to be admitted to trading on AIM on January 28, 2026, at 8:00 am. Disclaimer*
About this update from Talisman Metals Plc
[{"type":"text","content":"\n\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (\"UK MAR\"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF INSIDE INFORMATION (AS DEFINED UNDER UK MAR). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION, WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n \n \n27 January 2026\nOvoca Bio plc {to be renamed Talisman Metals PLC}\n(\"Talisman\" or the \"Company\")\nResult of General Meeting\nCompletion of Share Capital Reorganisation\nIssue of New Ordinary Shares\nResult of AGM\n \n \nOvoca Bio plc (to be renamed Talisman Metals PLC) is pleased to provide the results of the General Meeting held earlier today in connection with the acquisition of Tadeen International Limited and other matters (the \"Transaction\"). All resolutions were passed and accordingly completion of the Acquisition will proceed along with issue of the New Ordinary Shares of €0.02 each (the \"New Ordinary Shares\"), the Consideration Shares and Fundraising Shares.\nResult of General Meeting\nAt the General Meeting held today at 11am, all resolutions were passed on a show of hands.\nA copy of the Notice of General Meeting, contained in the Admission Document, is available on the Company's website, https://ovocabio.com. \nAs previously announced on 31 December 2025, completion of the Acquisition and Admission of the Enlarged Share Capital to trading on AIM is expected to commence on 28 January 2026 at 8:00am. The ISIN for the New Ordinary Shares is IE000XRZAWV1 and SEDOL is BV5DLB8.\nCapitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Admission Document.\n \nResult of AGM\nFurthermore, the Company has also held its AGM today and all resolutions proposed at the AGM were passed. A copy of the Notice of AGM is available on the Company's website.\n \nEnquiries:\n\n\n\n\nOvoca Bio plc\nTimothy McCutcheon, CEO\nin...